Today’s top gainers include the company Allergan plc (NYSE:AGN) which is in the industry Drugs – Generic, gaining 1.76% today. In the last week its performance is -4.21%, and -7.70% for the past quarter. Currently, Allergan plc, AGN has a target price of 300.24, so today’s gain of 1.76% is a significant step towards its target price. The GAP today is therefore 0.60%.
Allergan plc (NYSE:AGN), has a market cap of 92160.7, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 87.60%.
At the current price of 227.94, it has a dividend yield of *TBA, and its target price is 300.24. This is with a profit margin of 27.00%, and total debt/equity of 0.56. Allergan plc (NYSE:AGN) has a P/E of *TBA, as well as a forward P/E of 13.46.
With a current EPS of -6.14, and a forecasted EPS growth for next year at 21.03%,Allergan plc (NYSE:AGN) has had a EPS growth for the past five years at -50.40%. For the next five years EPS growth is projected to be 13.42%.
Performance for the year is -16.60%. Since its IPO date on 2/17/1993, the total performance to date is -27.06%.
Volume today for Allergan plc (NYSE:AGN), is 4290100, while its average volume is 3212.15. Whilst the total gain today was 1.76%, it did have a day high of -10.92%.
Volatility for this week has been at 3.25%, and 2.42% for the month. The 52-week low for Allergan plc, AGN has been 16.59%, while the 52-week-high has reached -29.36%.
Looking at its return of investments, which is -1.30%, and its return on assets is 3.00%. Allergan plc (NYSE:AGN) has an operating margin of -16.50%. With a sales growth of 1.50% quarter over quarter. Bearing in mind that Allergan plc, AGN is in the sector Healthcare, its long-term debt/equity is 0.52, and has a current ratio of 1 and 0.9 for quick ratio.
So what is the value of Allergan plc? Well its PEG is *TBA, and the P/S is 6, along with a P/B of 1.26. Meanwhile it has a p/cash of 181.92.